Biotechnology
183 industry stocks in the Biotechnology sector, with a combined market value of $1.11T. On average they are up 4.65% today and up 58% over the past year.
Stocks183
Combined market cap$1.11T
Average move today▲ 4.65%
Average 1-year return▲ 58.1%
Median P/E21.3
Avg dividend yield0.74%
Leading today
Biggest gainers in this group
Lagging today
Biggest decliners in this group
Breadth
How many members are up or down right now
158 advancing · 23 declining · 2 unchanged
All 183 stocks, largest first
| # | Stock | Price | Day | 1 year | Market cap | P/E | Yield | 52-week range |
|---|---|---|---|---|---|---|---|---|
| 1 | VRTX Vertex Pharmaceuticals | $547.09 | ▲ 0.85% | ▲ 33.6% | $138.71B | 35.7 | – | |
| 2 | MRNA Moderna | $254.19 | ▲ 5.27% | ▲ 935.8% | $101.48B | – | – | |
| 3 | REGN Regeneron Pharmaceuticals | $904.35 | ▲ 0.16% | ▲ 38.2% | $93.55B | 21.8 | 0.41% | |
| 4 | ARGX argenx SE | $927.21 | ▲ 3.63% | ▲ 8.5% | $58.31B | 47.4 | – | |
| 5 | ONC BeiGene | $406.96 | ▲ 5.09% | ▲ 27.2% | $46.49B | 160.9 | – | |
| 6 | GMAB Genmab | $53.63 | ▲ 1.69% | ▲ 87.1% | $33.47B | 34.9 | – | |
| 7 | RPRX Royalty Pharma | $67.30 | ▼ 0.40% | ▲ 77.9% | $29.97B | 37.8 | 1.37% | |
| 8 | ROIV Roivant Sciences | $38.88 | ▲ 6.17% | ▲ 88.6% | $28.08B | – | – | |
| 9 | INSM Insmed | $114.41 | ▲ 5.19% | ▼ 39.7% | $25.10B | – | – | |
| 10 | INCY Incyte | $119.65 | ▲ 1.39% | ▲ 12.9% | $24.39B | 18.7 | – | |
| 11 | BNTX BioNTech | $87.51 | ▲ 1.92% | ▼ 15.2% | $21.70B | – | – | |
| 12 | ALNY Alnylam Pharmaceuticals | $155.94 | ▼ 0.46% | ▼ 64.8% | $20.89B | 66.9 | – | |
| 13 | EXEL Exelixis | $69.57 | ▲ 1.25% | ▲ 70.5% | $16.98B | 25.0 | – | |
| 14 | ASND Ascendis Pharma A/S | $256.82 | ▲ 1.33% | ▲ 29.9% | $16.90B | – | – | |
| 15 | JAZZ Jazz Pharmaceuticals | $234.76 | ▲ 3.27% | ▲ 79.0% | $15.07B | – | – | |
| 16 | BBIO BridgeBio Pharma | $74.29 | ▲ 0.03% | ▲ 20.2% | $14.47B | – | – | |
| 17 | TECH Bio-Techne | $72.78 | ▲ 0.17% | ▲ 27.5% | $11.43B | 62.7 | 0.44% | |
| 18 | KYMR Kymera Therapeutics | $131.73 | ▲ 2.82% | ▲ 124.6% | $11.25B | – | – | |
| 19 | PCVX Vaxcyte | $63.89 | ▲ 3.18% | ▲ 53.4% | $10.11B | – | – | |
| 20 | MDGL Madrigal Pharmaceuticals | $399.63 | ▼ 0.12% | ▼ 18.3% | $9.28B | – | – | |
| 21 | TGTX TG Therapeutics | $59.83 | ▲ 3.18% | ▲ 85.6% | $9.16B | 21.6 | – | |
| 22 | IBRX ImmunityBio | $8.64 | ▲ 7.80% | ▲ 305.4% | $9.15B | – | – | |
| 23 | KRYS Krystal Biotech | $300.88 | ▲ 0.21% | ▲ 52.0% | $8.92B | 44.0 | – | |
| 24 | ARWR Arrowhead Pharmaceuticals | $58.16 | ▲ 1.22% | ▲ 48.3% | $8.22B | – | – | |
| 25 | TWST Twist Bioscience | $120.79 | ▲ 0.15% | ▲ 299.0% | $8.01B | – | – | |
| 26 | RYTM Rhythm Pharmaceuticals | $112.28 | ▲ 6.91% | ▲ 11.9% | $7.78B | – | – | |
| 27 | ABVX Abivax S.A. | $85.73 | ▲ 1.85% | ▼ 18.6% | $7.50B | – | – | |
| 28 | CYTK Cytokinetics | $53.69 | ▼ 3.35% | ▼ 10.8% | $7.48B | – | – | |
| 29 | CAI Caris Life Sciences | $25.23 | ▼ 3.07% | ▼ 1.5% | $7.24B | – | – | |
| 30 | AXSM Axsome Therapeutics | $132.37 | ▲ 1.98% | ▼ 4.2% | $6.96B | – | – | |
| 31 | CGON CG Oncology | $75.99 | ▲ 17.27% | ▲ 91.5% | $6.74B | – | – | |
| 32 | IONS Ionis Pharmaceuticals | $39.42 | ▲ 1.60% | ▼ 46.4% | $6.55B | – | – | |
| 33 | IMVT Immunovant | $30.53 | ▲ 7.54% | ▲ 30.7% | $6.31B | – | – | |
| 34 | KOD Kodiak Sciences | $99.30 | ▲ 9.10% | ▲ 463.2% | $6.24B | – | – | |
| 35 | BLTE Belite Bio | $154.19 | ▲ 7.68% | ▲ 36.2% | $6.21B | – | – | |
| 36 | LGND Ligand Pharmaceuticals | $306.20 | ▲ 2.41% | ▲ 51.2% | $6.12B | 50.0 | – | |
| 37 | MIRM Mirum Pharmaceuticals | $93.72 | ▲ 0.19% | ▲ 37.6% | $6.12B | – | – | |
| 38 | MANE Veradermics | $138.78 | ▲ 7.92% | – | $5.80B | – | – | |
| 39 | SRRK Scholar Rock | $46.94 | ▲ 3.16% | ▲ 62.1% | $5.72B | – | – | |
| 40 | COGT Cogent Biosciences | $31.65 | ▲ 6.98% | ▲ 113.5% | $5.49B | – | – | |
| 41 | PTCT PTC Therapeutics | $65.44 | ▼ 0.35% | ▼ 8.8% | $5.47B | 8.4 | – | |
| 42 | ERAS Erasca | $14.41 | ▲ 8.59% | ▲ 534.8% | $5.04B | – | – | |
| 43 | EWTX Edgewise Therapeutics | $45.04 | ▲ 15.87% | ▲ 162.5% | $4.93B | – | – | |
| 44 | CRSP CRISPR Therapeutics | $50.07 | ▲ 3.11% | ▼ 9.2% | $4.86B | – | – | |
| 45 | DNTH Dianthus Therapeutics | $86.03 | ▲ 3.64% | ▲ 137.1% | $4.84B | – | – | |
| 46 | TVTX Travere Therapeutic | $49.60 | ▲ 1.49% | ▲ 53.4% | $4.76B | – | – | |
| 47 | DFTX Definium Therapeutics | $33.27 | ▲ 9.59% | ▲ 184.4% | $4.47B | – | – | |
| 48 | RLAY Relay Therapeutics | $18.60 | ▲ 9.41% | ▲ 207.4% | $4.11B | – | – | |
| 49 | XENE Xenon Pharmaceuticals | $39.17 | ▲ 3.95% | ▲ 2.4% | $3.79B | – | – | |
| 50 | IOVA Iovance Biotherapeutics | $8.04 | ▲ 3.88% | ▲ 249.6% | $3.72B | – | – | |
| 51 | ACAD ACADIA Pharmaceuticals | $21.23 | ▼ 0.05% | ▼ 5.9% | $3.67B | 9.2 | – | |
| 52 | ELVN Enliven Therapeutics | $49.43 | ▲ 10.36% | ▲ 180.4% | $3.64B | – | – | |
| 53 | TNGX Tango Therapeutics | $21.50 | ▲ 3.02% | ▲ 173.2% | $3.63B | – | – | |
| 54 | VKTX Viking Therapeutics | $26.84 | ▲ 4.07% | ▼ 27.0% | $3.42B | – | – | |
| 55 | DYN Dyne Therapeutics | $18.07 | ▲ 4.09% | ▼ 1.6% | $3.39B | – | – | |
| 56 | TARS Tarsus Pharmaceuticals | $68.60 | ▲ 1.60% | ▲ 0.5% | $3.38B | – | – | |
| 57 | CELC Celcuity | $66.79 | ▲ 4.29% | ▼ 10.4% | $3.28B | – | – | |
| 58 | TLX Telix Pharmaceuticals | $9.63 | ▲ 2.23% | ▼ 0.8% | $3.26B | – | – | |
| 59 | VRDN Viridian Therapeutics | $28.49 | ▼ 0.21% | ▲ 3.8% | $3.24B | – | – | |
| 60 | ARQT Arcutis Biotherapeutics | $25.55 | ▼ 5.37% | ▲ 5.4% | $3.23B | – | – | |
| 61 | DNLI Denali Therapeutics | $20.07 | ▲ 1.77% | ▲ 33.6% | $3.22B | – | – | |
| 62 | IDYA IDEAYA Biosciences | $31.24 | ▲ 1.93% | ▲ 3.3% | $3.02B | – | – | |
| 63 | ZLAB Zai Lab | $25.48 | ▲ 12.74% | ▲ 16.3% | $2.87B | – | – | |
| 64 | ADMA ADMA Biologics | $12.73 | ▼ 3.63% | ▼ 12.3% | $2.82B | 21.2 | – | |
| 65 | VCEL Vericel | $54.62 | ▲ 5.48% | ▲ 40.3% | $2.79B | 170.7 | – | |
| 66 | BEAM Beam Therapeutics | $26.41 | ▲ 2.09% | ▲ 18.9% | $2.73B | – | – | |
| 67 | XNCR Xencor | $35.75 | ▲ 4.99% | ▲ 157.2% | $2.68B | – | – | |
| 68 | RCUS Arcus Biosciences | $18.28 | ▲ 3.34% | ▼ 5.3% | $2.63B | – | – | |
| 69 | PVLA Palvella Therapeutics | $175.92 | ▲ 12.16% | ▲ 126.0% | $2.57B | – | – | |
| 70 | PHVS Pharvaris | $34.39 | ▲ 5.72% | ▲ 59.3% | $2.41B | – | – | |
| 71 | CLDX Celldex Therapeutics | $29.87 | ▲ 5.66% | ▲ 30.4% | $2.35B | – | – | |
| 72 | COAG Hemab Therapeutics Holdings | $49.02 | ▲ 7.57% | – | $2.29B | – | – | |
| 73 | SEPN Septerna | $48.85 | ▲ 3.17% | ▲ 163.9% | $2.28B | – | – | |
| 74 | IMNM Immunome | $18.71 | ▲ 4.50% | ▲ 22.8% | $2.21B | – | – | |
| 75 | AUPH Aurinia Pharmaceuticals | $16.46 | ▲ 1.54% | ▲ 12.7% | $2.21B | 8.0 | – | |
| 76 | LKFT Lakefront Biotherapeutics | $33.45 | ▼ 0.33% | ▲ 6.1% | $2.20B | 6.1 | – | |
| 77 | RXRX Recursion Pharmaceuticals | $3.52 | ▲ 0.57% | ▼ 23.8% | $2.19B | – | – | |
| 78 | BHVN Biohaven | $14.48 | ▲ 4.17% | ▲ 75.3% | $2.19B | – | – | |
| 79 | VERA Vera Therapeutics | $29.79 | ▼ 1.18% | ▲ 23.1% | $2.15B | – | – | |
| 80 | FTRE Fortrea Holdings | $21.96 | ▲ 7.33% | ▲ 95.2% | $2.12B | – | – | |
| 81 | VIR Vir Biotechnology | $12.21 | ▲ 10.80% | ▲ 138.0% | $2.09B | – | – | |
| 82 | ZYME Zymeworks | $29.63 | ▲ 3.11% | ▲ 80.0% | $2.09B | – | – | |
| 83 | REPL Replimune | $21.62 | ▲ 7.99% | ▲ 160.2% | $2.05B | – | – | |
| 84 | TRVI Trevi Therapeutics | $14.33 | ▲ 11.87% | ▲ 30.2% | $2.04B | – | – | |
| 85 | TRAX First Tracks Biotherapeutics | $47.90 | ▲ 5.44% | – | $2.01B | – | – | |
| 86 | HRMY Harmony Biosciences | $33.11 | ▲ 1.97% | ▲ 5.3% | $1.94B | 12.2 | – | |
| 87 | ZBIO Zenas BioPharma | $28.26 | ▲ 8.99% | ▼ 15.9% | $1.92B | – | – | |
| 88 | SRPT Sarepta Therapeutics | $17.82 | ▲ 1.42% | ▲ 1.1% | $1.91B | – | – | |
| 89 | MAZE Maze Therapeutics | $34.19 | ▲ 5.10% | ▲ 19.5% | $1.90B | – | – | |
| 90 | MESO Mesoblast | $14.27 | ▲ 1.21% | ▼ 2.3% | $1.86B | – | – | |
| 91 | NVAX Novavax | $10.78 | ▲ 10.22% | ▲ 44.9% | $1.78B | 4.2 | – | |
| 92 | AGIO Agios Pharmaceuticals | $29.41 | ▲ 4.03% | ▼ 27.7% | $1.76B | – | – | |
| 93 | ABSI Absci Corp | $10.17 | ▲ 8.31% | ▲ 204.9% | $1.75B | – | – | |
| 94 | SLS Sellas Life Sciences | $8.42 | ▲ 6.85% | ▲ 429.6% | $1.70B | – | – | |
| 95 | BRVE Braveheart Bio | $18.60 | ▲ 6.80% | – | $1.67B | – | – | |
| 96 | NRIX Nurix Therapeutics | $15.30 | ▲ 3.10% | ▲ 24.3% | $1.67B | – | – | |
| 97 | PGEN Precigen | $4.47 | ▲ 5.92% | ▲ 14.6% | $1.60B | – | – | |
| 98 | IMCR Immunocore | $30.99 | ▲ 9.12% | ▼ 7.5% | $1.60B | – | – | |
| 99 | NTLA Intellia Therapeutics | $11.35 | ▲ 2.25% | ▲ 19.2% | $1.59B | – | – | |
| 100 | RARE Ultragenyx Pharmaceutical | $15.43 | ▼ 0.90% | ▼ 49.6% | $1.57B | – | – | |
| 101 | TYRA TYRA BIOSCIENCES, INC. | $21.15 | ▲ 1.24% | ▲ 47.7% | $1.45B | – | – | |
| 102 | KARD Kardigan | $15.52 | ▲ 11.98% | – | $1.45B | – | – | |
| 103 | GPCR Structure Therapeutics | $20.35 | ▲ 6.66% | ▼ 38.0% | $1.45B | – | – | |
| 104 | OCUL Ocular Therapeutix | $6.60 | ▲ 2.57% | ▼ 39.2% | $1.45B | – | – | |
| 105 | AAPG Ascentage Pharma | $15.43 | ▲ 1.98% | ▼ 51.4% | $1.44B | – | – | |
| 106 | KRSA Korsana Biosciences | $31.05 | ▲ 2.04% | ▲ 173.5% | $1.41B | – | – | |
| 107 | ANAB AnaptysBio | $46.45 | ▲ 1.91% | ▲ 75.7% | $1.39B | 8.3 | – | |
| 108 | LBRX LB Pharmaceuticals | $42.01 | ▲ 10.29% | ▲ 173.7% | $1.36B | – | – | |
| 109 | INVA Innoviva | $19.10 | ▼ 0.73% | ▼ 8.4% | $1.36B | 5.8 | – | |
| 110 | MLYS Mineralys Therapeutics | $15.33 | ▲ 0.59% | ▼ 59.7% | $1.36B | – | – | |
| 111 | ADRX Adarx Pharmaceuticals | $13.23 | ▼ 0.45% | – | $1.35B | – | – | |
| 112 | AVLN Avalyn Pharma | $29.15 | ▲ 9.30% | – | $1.29B | – | – | |
| 113 | GHRS GH Research | $18.61 | ▲ 0.92% | ▲ 37.9% | $1.28B | – | – | |
| 114 | NKTR Nektar Therapeutics | $37.26 | ▲ 3.07% | ▼ 33.4% | $1.27B | – | – | |
| 115 | DRTS Alpha Tau Medical | $13.72 | ▲ 3.16% | ▲ 255.4% | $1.27B | – | – | |
| 116 | SGP SpyGlass Pharma | $36.95 | ▲ 8.41% | – | $1.24B | – | – | |
| 117 | OMER Omeros | $16.92 | ▼ 0.88% | ▲ 156.8% | $1.22B | – | – | |
| 118 | VOR Vor Biopharma | $19.88 | ▲ 6.54% | ▲ 6.3% | $1.22B | – | – | |
| 119 | URGN UroGen Pharma Ltd | $24.75 | ▼ 3.81% | ▲ 6.5% | $1.21B | – | – | |
| 120 | SPTX Seaport Therapeutics | $21.50 | ▲ 5.44% | – | $1.15B | – | – | |
| 121 | MRVI Maravai LifeSciences | $7.52 | ▲ 7.74% | ▲ 162.0% | $1.12B | – | – | |
| 122 | JANX Janux Therapeutics | $17.63 | ▲ 9.78% | ▼ 33.4% | $1.08B | – | – | |
| 123 | SVRA Savara | $4.83 | ▲ 10.27% | ▲ 22.3% | $992.37M | – | – | |
| 124 | ANRO Alto Neuroscience | $25.16 | ▲ 15.04% | ▲ 117.8% | $987.33M | – | – | |
| 125 | MLTX MoonLake Immunotherapeutics | $11.53 | ▲ 6.76% | ▲ 8.5% | $981.28M | – | – | |
| 126 | JBIO Jade Biosciences | $15.07 | ▲ 6.88% | ▲ 64.0% | $958.41M | – | – | |
| 127 | IMTX Immatics | $6.36 | ▲ 2.91% | ▼ 29.7% | $951.68M | – | – | |
| 128 | ODTX Odyssey Therapeutics | $19.23 | ▲ 1.85% | – | $924.35M | – | – | |
| 129 | ORIC Oric Pharmaceuticals | $8.82 | ▲ 3.89% | ▼ 28.6% | $914.22M | – | – | |
| 130 | GLUE Monte Rosa Therapeutics | $10.57 | ▲ 3.12% | ▼ 14.1% | $903.21M | – | – | |
| 131 | IVA Inventiva | $3.80 | ▲ 4.68% | ▼ 5.2% | $897.69M | – | – | |
| 132 | CRVS Corvus Pharmaceuticals | $10.54 | ▲ 8.32% | ▲ 38.7% | $889.08M | – | – | |
| 133 | TBPH Theravance Biopharma(Delisted) | $0.00 | ▲ 0.00% | – | $884.18M | 8.3 | – | – |
| 134 | AKTS Aktis Oncology | $15.82 | ▲ 6.53% | – | $879.90M | – | – | |
| 135 | PHAR Pharming Group | $12.29 | ▼ 0.08% | ▼ 20.3% | $869.86M | 307.3 | – | |
| 136 | MGTX MeiraGTx Holdings | $9.00 | ▲ 5.76% | ▲ 6.3% | $864.39M | – | – | |
| 137 | SNDX Syndax Pharmaceuticals | $9.54 | ▲ 1.81% | ▼ 36.6% | $858.87M | – | – | |
| 138 | OBX Obsidian Therapeutics | $13.87 | ▲ 44.43% | – | $856.48M | 21.3 | – | |
| 139 | ANNX Annexon | $4.20 | ▲ 4.87% | ▲ 45.8% | $796.23M | – | – | |
| 140 | LXRX Lexicon Pharmaceuticals | $1.78 | ▲ 10.56% | ▲ 42.4% | $792.52M | – | – | |
| 141 | ALMS Alumis | $6.03 | ▲ 3.08% | ▲ 27.8% | $780.49M | – | – | |
| 142 | DNA Ginkgo Bioworks | $11.29 | ▲ 13.35% | ▲ 26.1% | $760.27M | – | – | |
| 143 | RIGL Rigel Pharmaceuticals | $39.65 | ▼ 13.26% | ▲ 12.7% | $746.61M | 2.0 | – | |
| 144 | SLDB Solid Biosciences | $6.59 | ▲ 6.63% | ▲ 62.3% | $735.51M | – | – | |
| 145 | OABI OmniAb | $5.03 | ▲ 4.14% | ▲ 264.5% | $733.68M | – | – | |
| 146 | ARDX Ardelyx | $2.88 | ▼ 3.68% | ▼ 48.5% | $723.95M | – | – | |
| 147 | NVCT Nuvectis Pharma | $20.91 | ▲ 17.74% | ▲ 240.6% | $719.07M | – | – | |
| 148 | SANA Sana Biotechnology | $2.37 | ▲ 1.28% | ▼ 42.1% | $710.13M | – | – | |
| 149 | SGMT Sagimet Biosciences | $9.85 | ▲ 8.00% | ▲ 31.0% | $698.45M | – | – | |
| 150 | ATTO Attovia Therapeutics | $15.27 | ▲ 1.80% | – | $697.09M | – | – | |
| 151 | ZVRA Zevra Therapeutics | $11.59 | ▲ 10.07% | ▲ 31.6% | $689.66M | 8.6 | – | |
| 152 | AURA Aura Biosciences | $6.56 | ▲ 3.47% | ▲ 22.6% | $680.30M | – | – | |
| 153 | FDMT 4D Molecular Therapeutics | $12.25 | ▲ 8.89% | ▲ 16.7% | $676.74M | – | – | |
| 154 | AVBP ArriVent BioPharma | $13.64 | ▲ 11.53% | ▼ 24.4% | $672.56M | – | – | |
| 155 | IMMX Immix Biopharma | $8.06 | ▲ 11.94% | ▲ 155.9% | $669.62M | – | – | |
| 156 | CADL Candel Therapeutics | $8.75 | ▲ 8.83% | ▲ 73.6% | $669.54M | – | – | |
| 157 | WVE Wave Life Sciences | $3.37 | ▲ 4.50% | ▼ 57.2% | $663.68M | – | – | |
| 158 | ANL Adlai Nortye Group | $10.28 | ▲ 6.20% | ▲ 563.2% | $662.01M | – | – | |
| 159 | DSGN Design Therapeutics | $10.21 | ▲ 5.58% | ▲ 35.1% | $653.81M | – | – | |
| 160 | KURA Kura Oncology | $7.27 | ▲ 6.91% | ▼ 26.3% | $646.74M | – | – | |
| 161 | OLMA Olema Pharmaceuticals | $7.33 | ▲ 8.43% | ▼ 12.2% | $641.36M | – | – | |
| 162 | GERN Geron | $0.99 | ▲ 4.18% | ▼ 7.5% | $637.67M | – | – | |
| 163 | APMD Apnimed | $15.10 | ▲ 6.64% | – | $628.62M | – | – | |
| 164 | ACRS Aclaris Therapeutics | $3.90 | ▲ 8.03% | ▲ 68.1% | $618.59M | – | – | |
| 165 | CLYM Climb Bio | $10.29 | ▲ 16.01% | ▲ 462.3% | $604.42M | – | – | |
| 166 | FTH Faeth Therapeutics | $22.05 | ▲ 10.69% | ▲ 142.3% | $569.86M | – | – | |
| 167 | SLBT SL Science | $0.94 | ▲ 4.16% | ▼ 91.0% | $525.71M | – | – | |
| 168 | VALN Valneva | $5.51 | ▼ 2.31% | ▼ 36.8% | $524.15M | – | – | |
| 169 | NGNE Neurogene | $25.31 | ▼ 1.33% | ▼ 5.4% | $506.49M | – | – | |
| 170 | GYRE Gyre Therapeutics | $4.76 | ▲ 18.70% | ▼ 34.0% | $504.72M | 238.0 | – | |
| 171 | RGNX Regenxbio | $7.62 | ▲ 3.25% | ▼ 32.0% | $503.85M | – | – | |
| 172 | CBIO Crescent Biopharma | $13.54 | ▲ 4.64% | ▲ 3.1% | $502.93M | – | – | |
| 173 | MNPR Monopar Therapeutics | $71.42 | ▲ 6.25% | ▼ 11.8% | $479.38M | – | – | |
| 174 | CTMX CytomX | $2.19 | ▲ 2.34% | ▼ 39.5% | $477.43M | – | – | |
| 175 | ETRA ELECTRA THERAPEUTICS INC | $7.80 | ▲ 6.12% | – | $476.58M | – | – | |
| 176 | EPRX Eupraxia Pharmaceuticals | $6.89 | ▲ 4.39% | ▲ 26.4% | $455.25M | – | – | |
| 177 | BLSM BlossomHill Therapeutics | $13.50 | ▲ 9.31% | – | $429.10M | – | – | |
| 178 | PHAT Phathom Pharmaceuticals | $5.25 | ▲ 3.35% | ▼ 60.4% | $426.78M | – | – | |
| 179 | PBYI Puma Biotechnology | $8.25 | ▼ 15.56% | ▲ 37.7% | $425.87M | 13.5 | – | |
| 180 | CRMD CorMedix | $5.32 | ▲ 1.72% | ▼ 50.6% | $414.66M | 2.6 | – | |
| 181 | ALT Altimmune | $2.08 | ▲ 5.58% | ▼ 49.4% | $404.60M | – | – | |
| 182 | AVTX Avalo Therapeutics | $6.93 | ▲ 4.52% | ▼ 54.0% | $400.71M | – | – | |
| 183 | ATAI AtaiBeckley | $0.00 | ▲ 0.00% | – | $0.00 | – | – |
"1 year" is the price change over the past 365 days. P/E is trailing. For reference only, not investment advice.